EVI2B Antibody (MEM-216) [HRP]
Novus Biologicals, part of Bio-Techne | Catalog # NBP2-62207H
Clone MEM-216 was used by HLDA to establish CD designation.
Conjugate
Catalog #
Key Product Details
Species Reactivity
Human
Applications
Flow Cytometry, Immunoprecipitation
Label
HRP
Antibody Source
Monoclonal Mouse IgG1 kappa Clone # MEM-216
Concentration
Please see the vial label for concentration. If unlisted please contact technical services.
Product Specifications
Immunogen
Raji cells
Specificity
The antibody BP53-12 recognizes defined epitope (aa 16-25) on human p53, a 50 kDa tumour suppressor found in increased amounts in a wide variety of transformed cells; it is frequently mutated or inactivated in many types of cancer.
Clonality
Monoclonal
Host
Mouse
Isotype
IgG1 kappa
Applications for EVI2B Antibody (MEM-216) [HRP]
Application
Recommended Usage
Flow Cytometry
Optimal dilutions of this antibody should be experimentally determined.
Immunoprecipitation
Optimal dilutions of this antibody should be experimentally determined.
Application Notes
Optimal dilution of this antibody should be experimentally determined.
Formulation, Preparation, and Storage
Purification
Protein A purified
Formulation
PBS
Preservative
No Preservative
Concentration
Please see the vial label for concentration. If unlisted please contact technical services.
Shipping
The product is shipped with polar packs. Upon receipt, store it immediately at the temperature recommended below.
Stability & Storage
Store at 4C in the dark.
Background: EVI2B
Alternate Names
CD361 antigen, D17S376, ecotropic viral integration site 2B, Ecotropic viral integration site 2B protein homolog, EVDBprotein EVI2B, EVI-2B
Gene Symbol
EVI2B
Additional EVI2B Products
Product Documents for EVI2B Antibody (MEM-216) [HRP]
Product Specific Notices for EVI2B Antibody (MEM-216) [HRP]
This product is for research use only and is not approved for use in humans or in clinical diagnosis. Primary Antibodies are guaranteed for 1 year from date of receipt.
Loading...
Loading...
Loading...
Loading...
Loading...
Loading...